$781 Million is the total value of Logos Global Management LP's 46 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 108.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | New | ALX ONCOLOGY HLDGS INC | $118,390,000 | – | 3,136,981 | +100.0% | 15.15% | – |
| KROS | Buy | KEROS THERAPEUTICS INC | $61,712,000 | +311.3% | 1,600,000 | +300.0% | 7.90% | +163.4% |
| NKTX | New | NKARTA INC | $61,538,000 | – | 2,047,178 | +100.0% | 7.88% | – |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $58,472,000 | -1.7% | 1,173,188 | -8.3% | 7.48% | -37.1% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $46,869,000 | +449.9% | 850,000 | +529.6% | 6.00% | +252.2% |
| TGTX | Buy | TG THERAPEUTICS INC | $46,830,000 | +182.8% | 1,750,000 | +105.9% | 5.99% | +81.1% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $38,618,000 | – | 275,000 | +100.0% | 4.94% | – |
| DYN | New | DYNE THERAPEUTICS INC | $32,393,000 | – | 1,604,392 | +100.0% | 4.15% | – |
| RPTX | Buy | REPARE THERAPEUTICS INC | $30,059,000 | +48.1% | 976,894 | +46.5% | 3.85% | -5.1% |
| BTAI | Buy | BIOXCEL THERAPEUTICS INC | $23,848,000 | +50.0% | 550,000 | +83.3% | 3.05% | -4.0% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $20,309,000 | -20.5% | 721,454 | -22.1% | 2.60% | -49.1% |
| ATHA | New | ATHIRA PHARMA INC | $18,844,000 | – | 1,020,812 | +100.0% | 2.41% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $17,796,000 | -31.6% | 1,200,000 | -40.0% | 2.28% | -56.2% |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $17,450,000 | – | 500,000 | +100.0% | 2.23% | – |
| CYTK | Sell | CYTOKINETICS INC | $16,238,000 | -13.9% | 750,000 | -6.2% | 2.08% | -44.9% |
| SAGE | New | SAGE THERAPEUTICS INC | $15,280,000 | – | 250,000 | +100.0% | 1.96% | – |
| CALT | Buy | CALLIDITAS THERAPEUTICS ABsponsered ads | $13,200,000 | +88.8% | 550,000 | +83.3% | 1.69% | +20.9% |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $12,375,000 | -13.6% | 5,500,000 | +37.5% | 1.58% | -44.6% |
| KYMR | New | KYMERA THERAPEUTICS INC | $9,723,000 | – | 300,920 | +100.0% | 1.24% | – |
| NRIX | New | NURIX THERAPEUTICS INC | $9,600,000 | – | 275,000 | +100.0% | 1.23% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $9,323,000 | – | 275,000 | +100.0% | 1.19% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $7,401,000 | – | 300,000 | +100.0% | 0.95% | – |
| RACA | New | THERAPEUTICS ACQUISITION COR | $7,190,000 | – | 500,000 | +100.0% | 0.92% | – |
| AKUS | Sell | AKOUOS INC | $7,090,000 | -30.0% | 310,000 | -31.1% | 0.91% | -55.2% |
| UMRX | New | UNUM THERAPEUTICS INC | $6,318,000 | – | 2,700,000 | +100.0% | 0.81% | – |
| INBX | New | INHIBRX INC | $5,608,000 | – | 311,578 | +100.0% | 0.72% | – |
| LSACU | LIFESCI ACQUISITION CORPunit 03/31/2025 | $5,440,000 | +23.6% | 400,000 | 0.0% | 0.70% | -20.8% | |
| PMVP | New | PMV PHARMACEUTICALS INC | $5,325,000 | – | 150,000 | +100.0% | 0.68% | – |
| PAND | New | PANDION THERAPEUTICS INC | $5,157,000 | – | 450,000 | +100.0% | 0.66% | – |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $5,006,000 | +577.4% | 330,000 | +474.2% | 0.64% | +333.1% |
| OM | New | OUTSET MED INC | $5,000,000 | – | 100,000 | +100.0% | 0.64% | – |
| ANNX | New | ANNEXON INC | $4,825,000 | – | 159,622 | +100.0% | 0.62% | – |
| PASG | PASSAGE BIO INC | $4,516,000 | -46.7% | 344,438 | 0.0% | 0.58% | -65.9% | |
| RLAY | New | RELAY THERAPEUTICS INC | $4,259,000 | – | 100,000 | +100.0% | 0.54% | – |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $3,777,000 | -44.5% | 300,000 | -46.7% | 0.48% | -64.5% |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $3,732,000 | -20.3% | 123,465 | 0.0% | 0.48% | -48.9% | |
| NARI | New | INARI MED INC | $3,451,000 | – | 50,000 | +100.0% | 0.44% | – |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $3,300,000 | – | 300,000 | +100.0% | 0.42% | – |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $3,097,000 | -78.7% | 136,715 | -70.0% | 0.40% | -86.4% |
| PANAU | New | PANACEA ACQUISITION CORPunit 99/99/9999 | $2,400,000 | – | 200,000 | +100.0% | 0.31% | – |
| AFIB | New | ACUTUS MED INC | $2,235,000 | – | 75,000 | +100.0% | 0.29% | – |
| CHAQU | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $2,110,000 | +0.5% | 200,000 | 0.0% | 0.27% | -35.7% | |
| BCTG | New | BCTG ACQUISITION CORP | $2,072,000 | – | 200,000 | +100.0% | 0.26% | – |
| FSDC | New | FS DEV CORP | $1,120,000 | – | 100,000 | +100.0% | 0.14% | – |
| ARYBU | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $1,100,000 | -5.2% | 100,000 | 0.0% | 0.14% | -39.2% | |
| RAPT | Sell | RAPT THERAPEUTICS INC | $1,001,000 | -77.7% | 31,100 | -79.9% | 0.13% | -85.8% |
| APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -12,600 | -100.0% | -0.09% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -200,000 | -100.0% | -0.12% | – |
| LUMO | Exit | LUMOS PHARMA INC | $0 | – | -50,000 | -100.0% | -0.16% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -158,484 | -100.0% | -0.30% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -121,128 | -100.0% | -0.42% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -361,945 | -100.0% | -0.56% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.63% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -900,000 | -100.0% | -0.92% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -110,000 | -100.0% | -0.92% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -750,000 | -100.0% | -0.95% | – | |
| ETNB | Exit | 89BIO INC | $0 | – | -290,000 | -100.0% | -1.16% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -600,000 | -100.0% | -1.23% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -91,841 | -100.0% | -1.34% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -325,000 | -100.0% | -1.36% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -1,165,000 | -100.0% | -1.37% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -410,000 | -100.0% | -1.50% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -150,000 | -100.0% | -1.79% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -400,000 | -100.0% | -2.16% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -455,000 | -100.0% | -2.87% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -625,000 | -100.0% | -3.04% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -1,200,000 | -100.0% | -3.26% | – |
| AMTI | Exit | APPLIED MOLECULAR TRANS INC | $0 | – | -664,186 | -100.0% | -3.34% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -268,500 | -100.0% | -3.38% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -295,000 | -100.0% | -3.93% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -200,000 | -100.0% | -6.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-11-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.